Hanmi Science Co., Ltd. (KRX: 008930)
South Korea flag South Korea · Delayed Price · Currency is KRW
28,250
+300 (1.07%)
Feb 5, 2025, 9:00 AM KST

Hanmi Science Revenue

Hanmi Science had revenue of 322.47B KRW in the quarter ending September 30, 2024, with 4.24% growth. This brings the company's revenue in the last twelve months to 1.28T, up 6.61% year-over-year. In the year 2023, Hanmi Science had annual revenue of 1.25T with 19.30% growth.

Revenue (ttm)
1,283.65B
Revenue Growth
+6.61%
P/S Ratio
1.48
Revenue / Employee
2.89B
Employees
444
Market Cap
1,892.60B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231,247.91B201.85B19.30%
Dec 31, 20221,046.05B95.89B10.09%
Dec 31, 2021950.16B92.78B10.82%
Dec 31, 2020857.38B40.76B4.99%
Dec 31, 2019816.62B108.62B15.34%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,364.39B
Celltrion 2,876.25B
Yuhan 2,008.84B
SK Biopharmaceuticals 511.33B
SK bioscience 201.30B
Hanmi Pharm. 1,566.25B
Hanall Biopharma 134.24B
Daewoong Pharmaceutical 1,416.63B
Revenue Rankings